当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Recombinant influenza vaccine in adults aged 50 years or older
The Lancet Respiratory Medicine ( IF 38.7 ) Pub Date : 2017-06-29 , DOI: 10.1016/s2213-2600(17)30261-8
Priya Venkatesan

Influenza viruses are grown in eggs to produce inactivated vaccines, but these viruses typically contain mutations in the genes coding for haemagglutinin, which might reduce vaccine effectiveness. A new study published in the New England Journal of Medicine has shown that a recombinant, quadrivalent influenza vaccine provided better protection against influenza-like illness than a standard-dose, egg-grown, inactivated influenza vaccine in adults aged 50 years or older.


中文翻译:

50岁或以上成年人的重组流感疫苗



流感病毒在卵中生长以生产灭活疫苗,但这些病毒通常在编码血凝素的基因中含有突变,这可能会降低疫苗的有效性。在《新英格兰医学杂志》上发表的一项新研究表明,对于50岁以上的成年人,重组的四价流感疫苗比标准剂量,鸡蛋生长的灭活流感疫苗能更好地预防类似流感的疾病。
更新日期:2017-08-10
down
wechat
bug